Información:
Error:
ID
34383
Descripción
Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00806481
Link
https://clinicaltrials.gov/show/NCT00806481
Palabras clave
Versiones (1)
- 17/1/19 17/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
17 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Kidney Failure, Chronic NCT00806481
Eligibility Kidney Failure, Chronic NCT00806481
- StudyEvent: Eligibility
Similar models
Eligibility Kidney Failure, Chronic NCT00806481
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
chronic kidney disease patients aged 18 to 80 years
boolean
ID.2
Item
chronic kidney disease stage 3 (defined as a glomerular filtration rate of 30-60 ml/min/1.73m2)
boolean
ID.3
Item
office blood pressure controlled to less than 140/90 mmhg for 12 months before entry into the study
boolean
ID.4
Item
total cholesterol less than 5.5 mmol/l
boolean
ID.5
Item
existing or previous treatment within 1 year with a phosphate binder or vitamin d analogue
boolean
ID.6
Item
uncontrolled hyperphosphataemia (serum phosphate >1.8 mmol/l)
boolean
ID.7
Item
uncontrolled secondary hyperparathyroidism (pth >80 pg/ml)
boolean
ID.8
Item
diabetes mellitus
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
moderate-severe cardiac valvular disease
boolean